Estrogen Receptor-negative Breast Cancer
1 competing product in clinical development for Estrogen Receptor-negative Breast Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eribulin mesylate + carboplatin | Eisai | Phase 2 | UNKNOWN | 31 |